EDGAR Filing Documents for 0001193125-21-100712

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-21-100712

Filing Date

2021-03-31

Accepted

2021-03-30 18:26:17

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d226148ds3.htm	S-3	526658
2	EX-1.2	d226148dex12.htm	EX-1.2	248062
3	EX-4.6	d226148dex46.htm	EX-4.6	346879
4	EX-4.7	d226148dex47.htm	EX-4.7	338507
5	EX-5.1	d226148dex51.htm	EX-5.1	37752
6	EX-23.1	d226148dex231.htm	EX-23.1	1674
7	GRAPHIC	g226148sp148.jpg	GRAPHIC	3061
8	GRAPHIC	g226148sp149.jpg	GRAPHIC	1730
	Complete submission text file	0001193125-21-100712.txt		1507552

Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT

Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400

F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)